INS and gestational diabetes: Furthermore, we lacked data on several important potential confounders, including detailed maternal nutritional profiles; continuous glycemic control metrics, such as daily glucose monitoring values or HbA1c and information on GDM therapy (e.g., diet, insulin, or oral agents); and genetic predispositions, all of which may influence miRNA expression and fetal growth trajectories independently.